Brown Brothers Harriman & Co’s Ligand Pharmaceuticals LGND Stock Holding History

Brown Brothers Harriman & Co’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$5.14K	Hold
2024 Q3	$4.8K	Buy
2020 Q1	–	Sell
2019 Q4	$30K	Buy
2018 Q1	–	Sell
2017 Q4	$20K	Buy